This study is evaluating a new bioresorbable (dissolvable) nasal dressing called OCEAN, which contains mometasone furoate (a steroid). It's designed for people undergoing sinus surgery for chronic rhinosinusitis (ongoing inflammation of the sinuses), with or without nasal polyps. Researchers want to see if OCEAN is safe and helps with healing after surgery, and if it works as well as a standard steroid-eluting (steroid-releasing) sinus stent. You could be eligible if you are 18 or older and scheduled for bilateral endoscopic sinus surgery. The study aims to enroll 110 participants and is currently recruiting.

Study design

This is a multicenter, randomized, single-blinded study comparing OCEAN to a steroid-eluting sinus stent in 110 participants across up to 13 sites in the United States.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The study will follow participants for up to 25 days to assess serious adverse events and endoscopic healing.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.